PROVIDER PROFILE · NPI 1568577906

Judy ChengMD

Hematology-OncologyStanford, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

504

Beneficiaries

—

Total drug cost

$3.4M

Distinct drugs

Brand share

37.9%

Top prescribed drugs

Prednisone48 claims

Anastrozole46 claims

Abiraterone Acetate45 claims

Imatinib Mesylate42 claims

Lenalidomide36 claims

QUALITY · MIPS · 2024

Final MIPS score

97.3

Quality

89.9

Cost

78.2

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.94%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$86

Payment records

By payment type

Food and Beverage$86

REFERRAL NETWORK

Where Judy Cheng's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
CITY & COUNTY OF SAN FRANCISCO	97	1,808
LUCE, JUDITH	28	99
Thienkhai Vu Diagnostic Radiology · San Francisco, CA	25	79
Terence Friedlander Hematology-Oncology · San Francisco, CA	13	56
Terry Lynch Diagnostic Radiology · San Francisco, CA	13	18
Alexander Rybkin Diagnostic Radiology · Santa Barbara, CA	13	51
COHEN, PIERRE-ALAIN	11	41

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history